Form D

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
CITIUS PHARMACEUTICALS, INC.
Jurisdiction of Incorporation/Organization
NEVADA
Year of Incorporation/Organization
Over Five Years Ago

Previous Name(s)

  • TRAIL ONE, INC.
  • TRAILONE, INC.
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

11 COMMERCE DRIVE
1ST FLOOR
CRANFORD, NJ 07016
Phone Number: subscription required

Item 3. Related Persons

Name
MYRON HOLUBIAK
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
LEONARD MAZUR
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
SUREN DUTIA
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
CAROL WEBB
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
WILLIAM KANE
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
HOWARD SAFIR
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
EUGENE HOLUKA
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JAIME BARTUSHAK
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 4. Industry Group

PHARMACEUTICALS

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

New Notice
Date of First Sale in this Offering:
04/03/2019

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Option, Warrant or Other Right to Acquire Another Security

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
0

Item 12. Sales Compensation

Recipient
H.C. WAINWRIGHT CO., LLC
Recipient CRD Number
NONE
(Associated) Broker or Dealer)
H.C. WAINWRIGHT CO., LLC
(Associated) Broker or Dealer CRD Number
375
Address
430 PARK AVENUE
NEW YORK, NY 10022
States of Solicitation
  • ALL STATES

Item 13. Offering and Sales Amounts

Total Offering Amount
428803
Total Amount Sold
428803
Total Remaining to be Sold
0
Clarification of Response

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
3

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
30016.0
Finders' Fees
0.0
Clarification of Response

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
OTHER THAN THE PAYMENT OF SALARIES AND OTHER COMPENSATION AND BENEFITS, NO OFFICER, DIRECTOR, MANAGER OR PROMOTER WILL RECEIVE ANY PAYMENTS FROM THE PROCEEDS OF THIS OFFERING.

Signature and Submission

Issuer Name
CITIUS PHARMACEUTICALS, INC.
Issuer Signature
/S/ MYRON HOLUBIAK
Signer Name
MYRON HOLUBIAK
Signer Title
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Signature Date
04/04/2019
WhaleWisdom Logo

Elevate your investments